ResMed Inc (RMD)
ResMed Inc. Daily Stock Update
ResMed Inc. Daily Stock Update
Utah Wildfires: U-Haul Offers 30 Days Free Storage to Evacuees of Iron and Cottonwood Fires
Capco récompensée par OpenAI pour son innovation et son leadership en matière d’IA responsable
21shares Announces Distributions on TETH, TSOL, THYP, TSUI and TDOT
Western Metallica Announces AGM Results
Viridian Therapeutics, Inc. - Viridian Therapeutics Announces U.S. FDA Approval and Launch of Lumvoa™ (veligrotug-vvze) for the Treatment of Thyroid Eye Disease
Viridian Therapeutics Announces U.S. FDA Approval and Launch of Lumvoa™ (veligrotug-vvze) for the Treatment of Thyroid Eye Disease
GameStop Provides Fiscal Year 2026 Outlook
Incyte annuncia lopinione positiva del CHMP per Opzelura® (ruxolitinib) crema per il trattamento della dermatite atopica moderata in pazienti adulti
Incyte gibt positive Stellungnahme des CHMP zu Opzelura ® (Ruxolitinib)-Creme zur Behandlung von Erwachsenen mit mittelschwerer atopischer Dermatitis bekannt